Flatiron’s former CMO & CSO, Amy Abernethy, and Dr. Rick Pazdur of the FDA discuss the agency’s engagement with real-world evidence, the path forward for RWE, and the future of cancer care at the 2018 Flatiron Research Summit. Hear Rick Pazdur's perspective.
PT39M18S
Flatiron Co-Founder Zach Weinberg and former CMO & CSO, Amy Abernethy, open the 2018 Flatiron Research Summit sharing their perspectives on the promise of real-world evidence. Hear Amy Abernethy's perspective.
PT54M1S
Thought leaders from the FDA, life sciences and Flatiron real-world data experts discuss current and future uses of regulatory-grade RWE at the 2018 Flatiron Research Summit. Learn more about regulatory applications.
PT1H0M21S
Discover how real-world endpoints are enabling new approaches and how Flatiron is partnering with regulatory and industry stakeholders to develop and validate them. Learn more about real-world endpoints.
PT42M06S
Flatiron's academic partners share their perspective on partnering with life sciences organizations on health outcomes research, and how RWE can be leveraged to drive greater collaboration. Learn more about the academic perspective on RWE.
PT44M52S
Amy Abernethy speaks with Greg Simon of the Biden Cancer Initiative about opportunities for innovation in the current healthcare system in order to accelerate treatment options for cancer patients. Hear Greg Simon's perspective.
PT45M37S
Flatiron team members discuss the evolving role of machine learning and natural language processing (NLP) in real-world evidence along with appropriate applications for these technologies. Learn more about machine learning and AI.
